To include your compound in the COVID-19 Resource Center, submit it here.

Onglyza saxagliptin: Phase IIIb data

A double-blind Phase IIIb trial in 455 Type II diabetics inadequately controlled on insulin with or without metformin showed that 5 mg Onglyza plus insulin with

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE